0001645113-21-000033.txt : 20210304
0001645113-21-000033.hdr.sgml : 20210304
20210304175528
ACCESSION NUMBER: 0001645113-21-000033
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210302
FILED AS OF DATE: 20210304
DATE AS OF CHANGE: 20210304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Leonard Frank X
CENTRAL INDEX KEY: 0001822879
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37565
FILM NUMBER: 21715619
MAIL ADDRESS:
STREET 1: 20 VALLEY STREAM PARKWAY,
STREET 2: SUITE 300
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NovoCure Ltd
CENTRAL INDEX KEY: 0001645113
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
BUSINESS PHONE: 44 (0)15 3475 6700
MAIL ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
FORMER COMPANY:
FORMER CONFORMED NAME: Novocure Ltd
DATE OF NAME CHANGE: 20150615
4
1
wf-form4_161489851500921.xml
FORM 4
X0306
4
2021-03-02
0
0001645113
NovoCure Ltd
NVCR
0001822879
Leonard Frank X
C/O NOVOCURE INC.,
20 VALLEY STREAM PARKWAY, SUITE 300
MALVERN
PA
19355
0
1
0
0
Chief Development Officer
Restricted Share Units
2021-03-02
4
S
0
430
152.053
D
82668
D
Restricted Share Units
2021-03-02
4
A
0
8709
0
A
91377
D
Options to Buy Ordinary Shares
153.09
2021-03-02
4
A
0
16003
0
A
2031-03-01
Ordinary Shares
16003.0
16003
D
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Share Units vested on February 27, 2021. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Represents restricted share units that are scheduled to vest in equal installments on each of March 2, 2022, 2023 and 2024, subject to the reporting person's continued employment through such dates.
Options to buy 16,003 ordinary shares will vest and become exercisable in equal installments on each of March 2, 2022, 2023, 2024 and 2025, subject to the reporting person's continued employment through such dates.
By: /s/ Steven Robbins, Attorney in Fact for Frank X. Leonard
2021-03-04